The FDA approved the first anti-inflammatory atheroprotective cardiovascular treatment to reduce risk of cardiovascular events.
Read the full post on Becker's Hospital Review - Healthcare News
FDA greenlights 1st anti-inflammatory drug for cardiovascular disease
